MoneyWorks4Me

Wanbury receives term loan facilities of Rs 60 crore from Tata Capital

27 Jun 2024 Evaluate

Wanbury has received a term loan facilities of Rs 60 crore from Tata Capital, Mumbai at 12.50% interest per annum repayable over a period of seven years. The funds received by the company will be utilized towards the long-term working capital and capex requirement. 

Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..